These publications were authored or co-authored by Quest Diagnostics staff.
FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.Quest Diagnostics Authors: Strom, C
Authors: Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W.
Genet Med. 2011;13:39-45.
Comparison between Langerhans cell concentration in lichen planopilaris and traction alopecia with possible immunologic implications.Authors: Hutchens KA, Balfour EM, Smoller BR.
Am J Dermatopathol. 2011;33:277-280.
Value of laboratory tests in employer-sponsored health risk assessments for newly identifying health conditions: analysis of 52,270 participants.Authors: Kaufman HW, Williams FR, Odeh MA.
PLoS One. 2011;6:e28201.
RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival.Authors: Lee CN, Heidbrink JL, McKinnon K, Bushman V, Olsen H, Fitzhugh W, Li A, Van OK, He T, Ruben SM, Moore PA.
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.Authors: Lee TS, Kantarjian H, Ma W, Yeh CH, Giles F, Albitar M.
PLoS One. 2011;6:e23396.
Mol Genet Metab. 2011;103:92-95.
Circ Cardiovasc Genet. 2011;4:565-573.
Methods Mol Biol. 2011;719:219-234.
Specialties: Pathology, Laboratory Medicine
Cerebrovasc Dis. 2012;33:80-85.